Healthcare Resource Utilization (HCRU)

Significantly Increased Length of Stay for T2DM Patients

Significantly Increased Length of Stay for T2DM Patients *All comparisons between cohorts are significant at P<0.001
Additional information can be found by downloading the full poster
T2DM patients (N=71,237)
Non-T2DM patients (N=244,970)
Please see the poster for demographic data.
  • T2DM patients had a significantly higher length of stay at index CV hospitalization and during subsequent hospitalizations. The mean number of bed-days was also higher among T2DM patients.

Incremental Burden of Type 2 Diabetes Mellitus in Patients Experiencing Cardiovascular Hospitalizations

Coutinho AD, Raju A, Wang W, et al.

Patients with T2DM Had Significantly Higher Number of Healthcare Visits

Chart depicting the economic burden of patients with type 2 diabetes mellitus hospitalized for heart failure *All comparisons between cohorts are significant at P<0.001
T2DM patients (N=71,237)
Non-T2DM patients (N=244,970)
Please see the poster for demographic data.
  • T2DM patients had a significantly higher number of visits across all settings of care, both all-cause and CVD-related.

Incremental Burden of Type 2 Diabetes Mellitus in Patients Experiencing Cardiovascular Hospitalizations

Coutinho AD, Raju A, Wang W, et al.

HCRU Utilization by T2DM Patients with CVD

Percentage of total visits or prescription claims for patients with type 2 diabetes mellitus and cardiovascular disease CVD - cardiovascular disease; HCRU - healthcare resource utilization; T2DM - type 2 diabetes mellitus.
T2DM with CVD (N=138,384)
Additional information can be found by downloading the full poster
Please see the poster for demographic data.
  • Despite comprising only 17.8% of the study sample, patients with T2DM and CVD utilized over 50% of all inpatient services, close to 30% of all outpatient services, and 22% of all prescriptions.

Disproportionately High Direct Economic Burden of Type 2 Diabetes Mellitus in Patients With Comorbid Cardiovascular Disease

Sander SD, Lunacsek O, Stafkey-Mailey D, et al.

Number of Visits was 2-3X Higher in the HF Cohort

Number of Visits was 2-3X Higher in the HF Cohort *All comparisons between cohorts are significant at P<0.001
Other outpatient visits may include labs, diagonstics, home health, etc. HF - heart failure.
Low Risk: HF (n=5,128); Non-HF (n=5,128)
High Risk: HF (n=301); Non-HF (n=301)
Please see the poster for demographic data.
  • The average number of visits was higher among the HF cohort compared to the non-HF cohort for all visit types.

The Economic Burden of Patients With Type 2 Diabetes Mellitus Hospitalized for Heart Failure

Stafkey-Mailey D, Fuldeore RM, Shetty S, et al.

Significantly Higher Number of Bed-days in HF Cohort

Significantly Higher Number of Bed-days in HF Cohort HF - heart failure.
Low Risk: HF (n=5,128); Non-HF (n=5,128)
High Risk: HF (n=301); Non-HF (n=301)
Please see the poster for demographic data.
  • Patients in the HF cohort had a significantly higher number of bed‑days during the post‑index period compared to patients in the non‑HF cohort among both high- and low‑risk patients.

The Economic Burden of Patients With Type 2 Diabetes Mellitus Hospitalized for Heart Failure

Stafkey-Mailey D, Fuldeore RM, Shetty S, et al.

Patients Who Died Had Significantly Greater HCRU

Patients Who Died Had Significantly Greater HCRU *All comparisons between cohorts are significant at P<0.001
Died (N=7,648)
Did Not Die (N=7,648)
Please see the poster for demographic data.
  • Patients who died had significantly more inpatient, emergency department, and physician office visits, as well as pharmacy claims, on average, compared to those who did not die.

The Direct Cost of Cardiovascular Disease-related Death in Patients with Type 2 Diabetes Mellitus in a Commercially Insured Population in the United States

Shetty S, Stafkey-Mailey D, Yue B, et al.